Food and Drug Law Weekly

Bristol-Myers Squibb - Abatacept inhibits progression of joint damage in rheumatoid arthritis

Burnham Institute, La Jolla - Novel and efficient inhibitors of anthrax lethal factor identified

CABG Medical, Inc. - Approval granted to expand trials of Holly Graft System into Europe

CHAD Therapeutics, Inc. - Oxygen therapeutics firm reports net income increased to $0.06 per share

CHU Rangueil, Toulousse - Adipose tissue-derived adult SCs share immunosuppressive properties with BM-MSCs

CV Therapeutics, Inc. - Biopharmaceutical firm reports option grants

Chiba University - Interleukin-2 gene delivery sends glioblastoma into remission in rats

Children's Hospital of Pittsburgh - Adult stem cells can multiply like embryonic stem cells do

Colorado Center for Bone Research, Lakewood - New findings in the area of osteoporosis described

Compound Therapeutics - Dr. John Mendlein named CEO; to help accelerate oncology pipeline

Coronado Industries, Inc. - Company announces publication of PNT monotherapy manuscript

Cranberry Institute - Industry group: Cranberries fight H. pylori, guard against stomach cancer

Crucell Holland BV, Leiden - Rabies virus-neutralizing epitope recognized by human monoclonal antibody

Crucell, NV - Human monoclonal antibody against West Nile shows promise in animal studies

Duke University - Prostate-specific antigen rose after primary prostate cancer therapy

Duska Therapeutics, Inc. - Company, U of Pennsylvania ink agreement for ATPotent preclinical studies

ETAP de Nancy-Brabois - Oligofructose-enriched inulin improves cognition and mood in rats

Eli Lilly & Company - Blood sugar controlled by inhaled insulin as well as by injection, study shows

Eli Lilly and Company - New data show effective treatment for painful diabetic neuropathy

Epigenomics AG - DNA methylation of PSAT1 determines response to tamoxifen treatment

Foundation Ciencia Vida, Santiago - B-cell epitopes recognized by sera from Andes virus-infected persons identified

Friedrich Loeffer Institute, Greifswald - Researchers' work adds to herpesvirus vaccines body of knowledge

Inst. for Trade, Standards, and Sustainable Dev. - ITSSD: Brazil Will Break International Law with Theft of U.S. Drug Patents

Lorus Therapeutics Inc. - U.S. FDA accepts proposal for rolling NDA for pancreatic cancer drug

Methodist DeBakey Heart Center - FDA approves first blood test to predict risk for stroke

Northwestern University - African-American screening rates higher in VA hospital

Pfizer Inc - Pharma company to acquire Vicuron Pharmaceuticals, Inc.

Philanthropy - Coalition for Pulmonary Fibrosis, partners to raise money for IPF

Phytomedics, Inc. - Biopharma company is exclusive licensee of inflammatory treatment

Regeneration Technologies, Inc. - Implant company receives FDA clearance for STERLING Interference Screw ST

SALVAT Laboratorios SA - FDA new drug application filed for CETRAXAL Otic solution

Scripps Research Institute - Lassa virus nucleoprotein protects against arenavirus challenge

Syneron Medical, Ltd. - FDA clears VelaSmooth for cellulite treatment

U.S. Centers for Disease Control & Prevention - Cost-effectiveness of meningococcal vaccine strategies in U.S. examined

U.S. Food & Drug Administration - Developing bacterial vaccines to prevent diarrheal diseases reviewed

U.S. Food and Drug Administration - FDA Tentatively Approves First Generic Nevirapine

Watson Pharmaceuticals, Inc. - Somerset files response to U.S. FDA letter on selegiline transdermal system